Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, Borthakur G, Mu H, Zeng Z, Tabe Y, Allen JE, Wang Z, Wencai M, Lee HC, Orlowski R, Sarbassov DD, Neelapu SS, McDonnell T, Miranda RN, Wang M, Kantarjian H, Konopleva M, Davis, RE, Andreeff M
H., Kim, D
Like insulin, virtually all peptides are injected into the skin using a very tiny needle
As reviewed before [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40], BPC 157s g-ng dose range applied alone, without carrier addition, and its application including via the per oral route, clinical evidence, and toxicology without LD1 can ascertain its practical applicability
No published case reports document permanent allodynia from semaglutide or tirzepatide use
The search strategy combined subject headings and free-text terms related to GLP-1 RAs